AT1R blockade reduces IFN-γ production in lymphocytes in vivo and in vitro

作者: J.O.N. A. Weidanz , Lynn M. Jacobson , Rebecca J. Muehrer , Arjang Djamali , Debra A. Hullett

DOI: 10.1111/J.1523-1755.2005.00318.X

关键词:

摘要: AT 1 R blockade reduces IFN-γ production in lymphocytes vivo and vitro. Background Type angiotensin II (Ang II) receptor (AT R) signaling induces proinflammatory responses. Recent studies suggest that T express R; yet the effects of Ang binding to on cells are poorly understood. We examined effect release cytokine, interferon-gamma (IFN-γ) by human Methods used an blocker losartan a randomized clinical trial kidney transplant recipients over 12-month period [AT ( N = 11) control 10)]. Peripheral blood lymphocytes, isolated from both cohorts, were analyzed enzyme-linked immunosorbent spot assays (ELISPOT) analyses real-time reverse transcription-polymerase chain reaction (RT-PCR) enumerate producing mRNA levels. The vitro assessed using alloreactive cytotoxic T-lymphocyte line. Alloreactive treated with or candesartan immunosorbant assay (ELISA) was measure protein release. line also blocker–treated prior determining intracellular cytokine staining. Results cohort had significant decrease peripheral P ≤ 0.05 for each time point) levels 0.01 vs. patients). Losartan decreased treatment inhibited II's furthermore Conclusion blockers may have clinically relevant immunomodulatory role blocking cells.

参考文章(19)
Haiying Liang, Virginia J. Venema, Xiaodan Wang, Hong Ju, Richard C. Venema, Mario B. Marrero, Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. Journal of Biological Chemistry. ,vol. 274, pp. 19846- 19851 ,(1999) , 10.1074/JBC.274.28.19846
SILVIA FERNANDEZ-CASTELO, EDUARDO S. ARZT, ANALIA PESCE, MARCELO E. CRISCUOLO, ALBERTO DIAZ, SAMUEL FINKIELMAN, VICTOR E. NAHMOD, Angiotensin II regulates interferon-γ production Journal of interferon research. ,vol. 7, pp. 261- 268 ,(1987) , 10.1089/JIR.1987.7.261
Shu-Meng Cheng, Shih-Ping Yang, Ling-Jun Ho, Tien-Ping Tsao, Deh-Ming Chang, Jenn-Haung Lai, Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1. British Journal of Pharmacology. ,vol. 142, pp. 933- 942 ,(2004) , 10.1038/SJ.BJP.0705785
J. Kunertradek, H. Stepien, J. Komorowski, M. Pawlikowski, Stimulatory effect of angiotensin II on the proliferation of mouse spleen lymphocytes in vitro is mediated via both types of angiotensin II receptors. Biochemical and Biophysical Research Communications. ,vol. 198, pp. 1034- 1039 ,(1994) , 10.1006/BBRC.1994.1147
Debra A. MacKenzie, Hans W. Sollinger, Debra A. Hullett, Role of CD4+ regulatory T cells in hyperbaric oxygen-mediated immune nonresponsiveness Human Immunology. ,vol. 61, pp. 1320- 1331 ,(2000) , 10.1016/S0198-8859(00)00214-7
Xiangmei Chen, Jianzhong Wang, Feng Zhou, Xiaodan Wang, Zhe Feng, None, STAT proteins mediate angiotensin II–induced production of TIMP-1 in human proximal tubular epithelial cells Kidney International. ,vol. 64, pp. 459- 467 ,(2003) , 10.1046/J.1523-1755.2003.00133.X
Brian J. Nankivell, Simon M. Gruenewald, Richard D.M. Allen, Jeremy R. Chapman, Predicting glomerular filtration rate after kidney transplantation. Transplantation. ,vol. 59, pp. 1683- 1689 ,(1995) , 10.1097/00007890-199506270-00007
Chandra Nataraj, Michael I Oliverio, Roslyn B Mannon, Peter J Mannon, Laurent P Audoly, Carmen S Amuchastegui, Phillip Ruiz, Oliver Smithies, Thomas M Coffman, None, Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway Journal of Clinical Investigation. ,vol. 104, pp. 1693- 1701 ,(1999) , 10.1172/JCI7451
Emanuela Napoleone, Angelomaria Di Santo, Marina Camera, Elena Tremoli, Roberto Lorenzet, Angiotensin-Converting Enzyme Inhibitors Downregulate Tissue Factor Synthesis in Monocytes Circulation Research. ,vol. 86, pp. 139- 143 ,(2000) , 10.1161/01.RES.86.2.139